High survival rate for stem cell transplants to treat (SCID)

January 24, 2002

DURHAM, N.C. - When performed within the first 28 days of birth, stem cell transplants have a 95 percent success rate in treating newborn babies with severe combined immunodeficiency (SCID), according to a long-term study by Duke University Medical Center researchers.

Additionally, when babies who receive these early transplants are compared with those who received the same transplants after the first four weeks of life, the earlier transplants appear to stimulate a more robust and effective immune system. This enhanced response may be due to reduced stresses on the thymus, an organ responsible for "training" immature immune cells to fight off disease, said the researchers.

The results of the Duke study, which was supported by the National Institutes of Health (NIH), were published today in the February issue of the journal Blood.

SCID is a rare disorder in which babies are essentially born with little or no immune system, leaving them unable to defend themselves from potentially life-threatening infections. The stem cells used for transplant are obtained from the bone marrow of related donors and infused into the baby to generate a "new" immune system.

During the past 19 years, the Duke team has performed stem cell transplants on 117 SCID patients. Of the 21 babies who received their transplants within the first 28 days of life, 20 are still alive and leading normal lives, the oldest being 19 years old, said the Duke researchers. For those 96 babies who received their transplants after 28 days, the survival rate is 73 percent.

"By transplanting these children very early, we were able to provide an immune system to protect them from opportunistic infections," said Duke pediatric immunologist Dr. Laurie Myers and lead author of the new analysis. "We have shown that by transplanting early, we can improve the survival rates of an already highly effective therapy.

"Twenty years ago, all of these babies would have died," Myers added. "A pathogen that would have little effect on a healthy baby could kill one with SCID."

The key to improving the chances of a baby with SCID lies in early detection. According to Myers, all that is required is a simple test after birth in which researchers count the number of lymphocytes, a type of white blood cell, in a blood sample. However, she added, since the incidence of SCID ranges from one in 50,000 to 100,000 births, most pediatricians do not routinely order lymphocyte counts for this rare disorder.

"If, however, there is a family history of SCID, most parents want their baby tested," Myers said. "In our study, we identified nine of the 21 babies before birth and 12 immediately after, and in all cases there was a family history, so we were able to do the transplant shortly after birth."

On average, babies are first diagnosed with SCID after the age of 6 months. By that time the baby has probably suffered many infections and has not thrived as healthy babies would, Myers said. One effect of these repeated infections, the researchers believe, is undue stress on the thymus.

The thymus is critical in the development of key immune system cells known as T cells. These potent cells begin life in the bone marrow as stem cells, then migrate to the thymus where they divide, mature and receive their "marching orders" for the defense of the body.

"Researchers believe babies with SCID who are transplanted earlier have a thymus that hasn't been stressed by infections and so can turn the donated stem cells into functioning T cells," Myers said. "In the babies with early transplants, we saw a significantly higher number of T cells, and this was most evident from three months to three years after transplantation, a critical time in the development of defenses against common childhood infections."

The transplant itself is relatively straightforward. Physicians begin by removing bone marrow cells from the donor's hip. Researchers then remove the donor's mature T cells to avoid a condition known as graft-vs.-host disease, in which the donor's immune cells attack the recipient. The resulting stem cells are then infused into the baby.

"The cells know where to go, and eventually go to the thymus," Myers explained. "Within one month, we can see a significant increase in the number of new immune cells, and by three months, the levels are normal. Those who received the transplants in the first 28 days had more T cells earlier."

The Duke SCID program, which is one of the few in the country specializing in this treatment, was developed and is led by Dr. Rebecca Buckley, chief of pediatric allergy and immunology.

Other authors on the paper were Duke's Dr. Dhavalkumar Patel and Dr. Jennifer Puck of the NIH.
-end-
Note to editors: Dr. Laurie Myers can be reached at 919-684-6534 or at myers019@mc.duke.edu
A photo of Myers is available at http://www.dukemednews.duke.edu/gallery/detail.php?id=515

Duke University Medical Center

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.